Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Disposal

27 Apr 2006 17:09

Compagnie de Saint-Gobain27 April 2006 April 27, 2006 press release DISPOSAL OF SAINT-GOBAIN CALMAR Saint-Gobain has signed today an agreement regarding the sale of its subsidiarySaint-Gobain Calmar to MeadWestvaco Corporation. Calmar is a leading globalmanufacturer of plastic dispensing and spraying systems for cosmetics andfragrance, personal care as well as pharmaceutical industries. The transaction values Calmar at $745 million (of which $710 million in cashpaid by MeadWestvaco and $35 million of eliminated commitments by Saint-Gobain).In 2005, Calmar reported a pro-forma EBITDA of $72.7 million. Acquired by the Saint-Gobain Group in 1998, Calmar reported pro-forma sales of$403 million in 2005 and has approximately 2,700 employees based in 10production sites. Calmar will benefit from MeadWestvaco's financial capacity and global packagingstrategy, which should support its future development as a major player in itsbusiness. With annual revenues exceeding $6 billion, MeadWestvaco is a leading globalpackaging company that delivers high-value packaging solutions and products tocompanies in the food and beverage, media and entertainment, personal care,cosmetic and healthcare industries. MeadWestvaco employs approximately 23,000people around the world. The completion of the transaction, which is subject to the approval of therelevant anti-trust authorities, should be effective before the end of June2006. As it was communicated following the acquisition of BPB, the Saint-Gobain Groupis implementing a dynamic strategy of active portfolio management, consistentwith its business model. Investor Relations Department Mrs Florence TRIOU-TEIXEIRA Tel.: +33 1 47 62 45 19Mr Alexandre ETUY Tel.: +33 1 47 62 37 15 Fax.: +33 1 47 62 50 62 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Feb 20165:10 pmRNSAnnual Results
19th Jan 20167:57 amRNSJV announcement
13th Jan 20168:19 amRNSNew capacity
5th Jan 20165:18 pmRNSAcquisition
4th Jan 20164:50 pmRNSAcquisition
7th Dec 201512:48 pmRNSAcquisition
26th Nov 20156:29 pmRNSShares cancellation
30th Oct 20159:27 amRNSDisposal
29th Oct 20154:58 pmRNSDisposal
28th Oct 20155:16 pmRNS3rd Quarter Results
7th Oct 20154:54 pmRNSDisposal
5th Oct 20154:53 pmRNSCancellation of shares
16th Sep 20157:00 amRNSAcquisition
15th Sep 20157:59 amRNSDisposal
2nd Sep 20157:00 amRNSAcquisition
1st Sep 20157:02 amRNSProspectus Supplement
27th Aug 20155:56 pmRNSHalf Yearly Report
29th Jul 20155:02 pmRNSHalf Yearly Report
29th Jul 20157:51 amRNSSaint-Gobain reinforces its Gypsum business in US
28th Jul 201510:44 amRNSAcquisition
27th Jul 20157:40 amRNSAcquisition
23rd Jul 201512:03 pmRNSAcquisition
20th Jul 20155:02 pmRNSRe Joint Venture
17th Jul 20155:50 pmRNSPublication of Prospectus
1st Jul 20155:10 pmRNS2014 Dividend
8th Jun 20157:08 amRNSDisposal
5th Jun 20159:33 amRNSAGM Statement
1st Jun 20154:51 pmRNSAcquisition
6th May 20154:46 pmRNSAcquisition
5th May 20157:01 amRNSAcquisition
28th Apr 20155:02 pmRNS1st Quarter Results
15th Apr 20157:00 amRNSAcquisition
14th Apr 20158:41 amRNSAcquisition
7th Apr 20154:55 pmRNSAcquisition
2nd Apr 20155:40 pmRNSFinal Terms
1st Apr 20156:28 pmRNSAcquisition
4th Mar 201512:06 pmRNSProspectus Supplement
25th Feb 20155:15 pmRNSAnnual Results
10th Feb 20157:52 amRNSDisposal
26th Jan 20159:15 amRNSAcquisition
16th Jan 20154:45 pmRNSAcquisition
15th Jan 201511:46 amRNSAcquisition
23rd Dec 20142:32 pmRNSFinal Terms
8th Dec 20147:04 amRNSAcquisition
1st Dec 20144:51 pmRNS2 Directors representing employees at Saint-Gobain
27th Nov 20145:31 pmRNSSaint-Gobain to cancel 6.1 million shares
29th Oct 20144:45 pmRNSNew plant
27th Oct 20144:58 pmRNSNew plant
27th Oct 20147:56 amRNSAcquisition
23rd Oct 20144:46 pmRNS3rd Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.